Helus Pharma Rings the Nasdaq Stock Market Opening Bell
Helus Pharma (Nasdaq: HELP), a clinical-stage pharmaceutical company committed to helping minds heal through the development of novel serotonergic agonists (NSAs), visits the Nasdaq MarketSite in Times Square to mark the company’s recent U.S. stock exchange listing on Nasdaq and the launch of its new corporate identity.
In honor of the occasion, Eric So, Co-Founder and Executive Chairman rings the Opening Bell.
Watch a Helus Pharma brand video introducing the company’s next chapter: https://vimeo.com/1150186328